deltatrials
Completed NCT01136330

DM1 Heart Registry - DM1 Respiratory Registry

Cardiac and Respiratory Prognostic Factors in Patients With Myotonic Dystrophy Type 1

Sponsor: Institut de Myologie, France

Updated 6 times since 2017 Last updated: Feb 17, 2012 Started: May 31, 2010 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

Listed as NCT01136330, this observational or N/A phase trial focuses on Myotonic Dystrophy and remains completed. Sponsored by Institut de Myologie, France, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

Show 1 earlier version
  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut de Myologie, France
Data source: Institut de Myologie, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Paris, France